https://www.selleckchem.com/products/ABT-263.html
5%) than in the EHA group (22.6%) (p = 0.04). A similar portion of patients in both groups achieved favorable outcome at midterm follow-up (77.3% vs 73.6%, p = 0.87). DHA patients (62.3%) received conventional coiling more often than EHA patients (41.5%) (p = 0.03). CONCLUSIONS DHA patients are at an increased risk of cerebral infarction. Nevertheless, state-of-the-art neurointensive care treatment can result in a good clinical outcome.OBJECTIVE According to the latest WHO classification of tumors of endocrine organs in 2017, plurihormo
Curtir
Comentario
Compartilhar
